Skip to main content
. 2023 Oct 31;28(21):7372. doi: 10.3390/molecules28217372
AChE Acetylcholinesterase
AD Alzheimer’s disease
ALT Alanine aminotransferase
ASE Accelerated solvent extraction
AST Aspartate aminotransferase
BBB Blood–brain barrier
CAT Catalase
COX-2 Cyclooxygenase-2
CUPRAC Cupric ion reducing antioxidant capacity
CYPs Cytochromes P50
ED50 Median effective dose
ESI Electrospray ionization
FRAP Ferric reducing ability of plasma
fEPSP Field excitatory postsynaptic potentials
HSP Heat shock proteins
HSF Heat shock Factors
HT2A Hydroxy-Tryptamine receptor
IC50 Half maximal inhibitory concentration
I. P Intraperitoneal
Keap1 Kelch-like ECH-Associating protein 1
Kg Kilogram
LD50 Median lethal dose
LPS Lipopolysaccharides
LTP Long-term potentiation
MAO Monoamine oxidase
Mg Milligram
µg Microgram
MIC Minimum inhibitory concentration
Nrf2 Nuclear factor erythroid 2-related factor 2
Nm Nanometer
PD Parkinson’s disease
P. O Per Oral
QTOF-MS Quadrupole time-of-flight mass spectrometry
SOD Superoxide dismutase
TPC Total phenolic content
TFC Total flavonoid content
UDP Uridine diphosphate
UGT UDP-glucuronosyl transferase
UHPLC Ultra high-performance liquid chromatography
w/w Weight for weight